08:30 – 10:15 | Symposium # 1 ‐ Lung inflammation
Chair: Patrícia Silva

• • Ana Paula Duarte, PUCRS
    The therapeutic use of bacterial lysate during respiratory infections
  • Marco Aurélio Martins, FIOCRUZ
    Microcomputed Tomography Imaging for Quantitative Assessment of Mice Lung Abnormal Aeration
  • Luciana Pádua Tavares, Harvard Medical School – USA
    Resolution of inflammation in the lungs: key mechanisms for host protection in pneumonia
  • Short Talk 1
    Flávia Braga Martins
    Intranasal administration of lactate modulates alveolar macrophage polarisation and reduces alveolar inflammation
  • Short Talk 2
    Tamara Silva Rodrigues
    The role of inflammasome activation in endothelial cells during coronavirus infection

10:15 – 10:40 | Coffee Break

10:40 – 12:30 | Symposium # 2 ‐ Gut inflammation
Chair: Daniele G. de Souza

• • Marco Vinolo, UNICAMP
    Exploring the molecular mechanisms underlying host-microbiota interactions
    
  • Vinicius Oliveira, UFABC
    Shaping host metabolism in gut inflammatory diseases
  • Marcelo Bozza, UFRJ
    Disease tolerance dictates the microbiome composition and IBD susceptibility
  • Short Talk 3
    Isadora Maffra de Oliveira
    Activation of the NLRP3 inflammasome in response to leishmania infantum induces the recruitment of immune cells and the formation of inflammatory foci, which is important for controlling infection in the liver of mice
  • Short Talk 4
    Jéssica Assis Pereira
    Butyrate promotes migration of ccr2+ plasmacytoid dendritic cell and protects against pulmonary infection by covid-19 in experimental model

12:30 – 13:30 | Poster Setup

12:30 – 14:30 | Lunch

14:30 – 16:15 | Symposium # 3 ‐ T cell and inflammation
Chair: Cláudia F. Benjamim

• • Vinicius Cotta de Almeida, FIOCRUZ
    Integrating in silico, genetic and immunotherapeutic approaches to analyze the role of VLA-4 integrin in T-cell biology
  • Pauline Soulas-Sprauel, Strasbourg University – France
    Impact of STING gain of function on lymphocyte development and functions
  • Raphael Peres, FMRP/USP
    Unravelling the impact of regulatory T cells on therapeutic response in inflammatory bowel disease
  • Short Talk 5
    Caroline Vitória de Oliveira
    Impact of STING signaling pathway on the differentiation and function of regulatory T cells
  • Short Talk 6
    Samuel Oliveira
    Sarm1 controls the differentiation of distinct subsets of CD4 T cells and protects against experimental autoimmune colitis

16:15 – 16:45 | Coffee Break

16:45 – 17:30 | Conference
Chair: Fernando Q. Cunha

• • Patrick Legembre, University Limoges – France
    Soluble FasL contributes to the pathology severity in ANCA vasculitis patients

17:30 – 18:30 | SBIn General Assembly

17:30 – 19:30 | Poster Session

20:30 | Dinner (Subjected to Reservation and Ticket Purchase)
Venue: Gran Steak
Address: Avenida Itatiaia, n. 1435 – Ribeirão Preto – SP
View on map

08:30 – 10:10 | Symposium # 4 ‐ Chronic Inflammation
Chair: Niels Olsen S. Câmara

• • Vanessa Pinho – UFMG
    The role of annexin-A1 in regulating the inflammatory response associated with Graft-versus-Host Disease (GVHD)
  • Luiz O. Leiria, FMRP/USP
    Unveiling the role of maternal and child humoral immune response in metabolism and thermogenesis
  • Denise Fonseca, ICB/USP
    Infection-induced disruption of the cholinergic pathway impacts mesenteric immune tone and host capacity to induce type 2 immunity
  • Flávio Almeida, UFMG
    Reduction of synoviocyte activation by pro-resolving molecules as a strategy for controlling osteoarthritis

10:10 – 10:40 | Coffee Break

10:40 – 12:30 | Symposium # 5 ‐ Cell signaling and inflammation
Chair: Nicolas Riteau

• • Larissa Dias Da Cunha, FMRP/USP
    Regulation of macrophage function at the cell trafficking crossroads
  • Djalma de Souza Lima Junior, NIH/USA
    Endogenous retrovirus control of host immunity
    
  • Anamélia Bocca, UnB
    Chronic infection or latency? Which one is the best way to survive in macrophages?
  • Short Talk 7
    César Luís Barbosa
    Chronic chagas disease and acute sars-cov2 experimental infection/coinfection: promising role of SOCS2 as a therapeutic target
  • Short Talk 8
    Roberta Nicolli Sagiorato
    Butyrate demonstrates immunomodulatory effects by attenuating psoriatic inflammation in mice

12:45 – 14:30 | Lunch

14:30 – 16:15 | Symposium #6 ‐ Host-pathogen interactions and inflammation
Chair: Dario S. Zamboni, FMRP‐USP

• • Martin Olivier, McGill University – Canada
    Leishmania exosomes and its vector: Impact on skin hyperinflammation during cutaneous Leishmaniasis
  • Lucas Nicolau, UFDPAR
    SARS-CoV-2 Spike protein harbours clues to the COVID-19 in the GI tract: involvement of innate immunity of the peritoneum and gut
  • Daniel de Oliveira Gomes, UFES
    Lesional inflammatory environment induces immunosenescence and shapes T cell function towards a pathogenic role in human cutaneous leishmaniasis
  • Short Talk 9
    Letícia Soares Azevedo
    Folic acid restriction associated with zika virus infection during pregnancy in female mice leads to impaired offspring development in the pre and postnatal period
  • Short Talk 10
    Yugo Araújo Martins
    Optimizing pulmonary delivery and immunomodulation for respiratory diseases via virus transport-inspired nanoparticles

16:15 – 16:40 | Coffee Break

16:40 – 17:30 | Closing Conference
Chair: Sandra Fukada

• • Zeinab Abdullah, University of Bonn – Germany
    The unconventional gang gets a new member with immune therapeutic potential

17:30 | Closing Remarks
Niels Olsen Saraiva Câmara, ICB/USP